Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Raises Additional $574K in Debt Placement

NEW YORK (GenomeWeb News) – Toronto-based GeneNews has raised C$718,783 (US$574,000) through the second tranche of a private placement of debentures.

The firm said that it has accepted subscriptions for five-year, 15 percent redeemable convertible secured debentures. The 15 percent annual interest will be paid upon the earlier of maturity, conversion, or redemption of the debentures.

Each purchaser of a debenture will also receive one warrant for every C$.25 of principal amount of their debenture. Each of those warrants is exercisable into GeneNews common shares for a period of 36 months following the date of issuance at a price of C$.25 per common share.

GeneNews said that it would use proceeds from the debt placement for general working purposes, the continued marketing of its ColonSentry test in Canada, and the pre-launch preparation for the commercial launch of the test in the US and Asia.

The firm announced at the end of December that its board had authorized the sale of up to C$3.45 million of debentures. In the first tranche of the debt offering, GeneNews brought in C$1.1 million (US$900,000).

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.